Structure-based design of chimeric antigens for multivalent protein vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Structure-based design of chimeric antigens for multivalent protein vaccines ; volume:9 ; number:1 ; day:13 ; month:3 ; year:2018 ; pages:1-10 ; date:12.2018
Nature Communications ; 9, Heft 1 (13.3.2018), 1-10, 12.2018
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Hollingshead, S.
- Beteiligte Personen und Organisationen
-
Jongerius, I.
Exley, R. M.
Johnson, S.
Lea, S. M.
Tang, C. M.
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-03146-7
- URN
-
urn:nbn:de:1111-201805132991
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hollingshead, S.
- Jongerius, I.
- Exley, R. M.
- Johnson, S.
- Lea, S. M.
- Tang, C. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
P12-07. Novel HIV vaccines using chimeric influenza HA vectors
Exploring the potential of novel multivalent DNA-based vaccines
Exploring the potential of novel multivalent DNA-based vaccines
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Chimeric Antigen Receptor T-Cell Therapy
Expression and immunogenicity of DNA vaccines encoding chimeric antigens with a stress protein capturing, viral J-domain
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy